Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    Home»HealthCare»TransCanna Announces Closing Date for CDN$16 Million Brokered Private Placement of Units
    HealthCare

    TransCanna Announces Closing Date for CDN$16 Million Brokered Private Placement of Units

    Marie JonesBy Marie JonesApril 2, 2019No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Vancouver, BC – (ACN Newswire) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that the closing date of the recently announced private placement will be on Thursday, April 4th, 2019.

    “The private placement was oversubscribed, allowing us to bring in a significant number of new investors and materially increase our shareholder base. In fact, the volume of subscriptions caused a slight delay in our original anticipated closing date. With that said, we are extremely thankful to all of the investors who are participating in the private placement,” stated Jim Pakulis, CEO of TransCanna.

    As reported in our March 14th press release, as a result of significant demand, the Company’s brokered private placement of 5,000,000 units of the Company (the “Units”) at a price of CDN$2.00 per Unit (the “Offering”), is oversubscribed. Consequently, the Company increased the size of the Offering by sixty percent to a maximum of 8,000,000 Units to raise gross proceeds of CDN$16,000,000. The terms of the Units under the Offering remain unchanged as previously announced in our March 14th and February 20th press releases. The Offering is being conducted by a syndicate of agents co-led by Haywood Securities Inc. and Canaccord Genuity Corp., and including Gravitas Securities Inc.

    For further information, please visit the Company’s website at www.transcanna.com.

    About TransCanna Holdings Inc.

    TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

    For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

    Media Contact
    TransCanna@talkshopmedia.com
    604-738-2220

    On behalf of the Board of Directors
    James Pakulis
    Chief Executive Officer
    Telephone: (604) 609-6199

    The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the anticipated timing of the closing of the financing and the expected proceeds therefrom. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

    Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/43812

    TransCanna
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleChina Dynamics and CSIC Sign Strategic Cooperation Agreement Jointly Develop Next Generation Electric Vessel Business and New Electric Ferryboats
    Next Article Ntegrator Secures Contract Worth S$58.6 Million from a Regional Service Provider

    Related Posts

    CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth

    October 27, 2026

    Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026

    October 27, 2026

    Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization

    October 27, 2026
    Add A Comment

    Comments are closed.

    Latest News

    • Garuda Indonesia Advances Digital Transformation, Expands Travel Flexibility with Upgraded Manage My Booking Service
    • Chervon Launches Advanced Momentum Program (AMP) to Hire & Develop the Next Generation of Leaders
    • Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers
    • OMRON Healthcare Begins Full-Scale Production at First Factory in India
    • Rasa Light Je: Spritzer Sparkling Invites Malaysians to Go Light on Themselves with a Positive Approach to Everyday Wellbeing
    • Garuda Indonesia Group’s Transformation Programme Drives 13.2% Revenue Growth to US$2.71 Billion Amid High Jet Fuel Prices
    • CIMC Group Announces Results for the First Three Quarters of 2026
    • TANAKA MIRAI Lab., JAF MEDIA WORKS, and Della Begin Joint Research to Visualize Drivers’ Conditions through Analysis of Sweat Components
    • U.S. Polo Assn. Executes Early on Europe’s Digital Product Passport Mandate
    • COSCO SHIPPING Ports Announces 2026 Third Quarter Results
    © 2026 BusinessNewsAsia.com

    Type above and press Enter to search. Press Esc to cancel.